|
Market Closed -
Nasdaq
04:00:00 2026-10-20 pm EDT
|
5-day change | 1st Jan Change | ||
| 71.03 USD | +2.20% |
|
+0.30% | -13.25% |
| Market Cap | 3.12B 2.77B 2.57B 2.33B 4.38B 295B 4.45B 30.85B 12.12B 155B 11.69B 11.45B 493B | P/E 2026 * |
-14.8x | P/E 2027 * | 533x |
|---|---|---|---|---|---|
| Enterprise Value | 2.78B 2.48B 2.29B 2.08B 3.91B 263B 3.97B 27.53B 10.81B 138B 10.43B 10.21B 440B | EV / Sales 2026 * |
3.82x | EV / Sales 2027 * | 2.87x |
| Free-Float |
97.31% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TARS | Delayed | |
CBOE
| TARS | Real-time |
Last Transcript: Tarsus Pharmaceuticals, Inc.
| 1 day | +2.20% | ||
| 1 week | +0.30% | ||
| Current month | -9.64% | ||
| 1 month | -9.04% | ||
| 3 months | +26.28% | ||
| 6 months | +7.67% | ||
| Current year | -13.25% |
| 1 week | 67.93 |  | 74.94 |
| 1 month | 67.93 | | 79.1 |
| Current year | 53.89 | | 91.53 |
| 1 year | 53.89 | | 91.53 |
| 3 years | 12.84 | | 91.53 |
| 5 years | 10.8 | | 91.53 |
| 10 years | 10.8 | | 91.53 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 48 | 2018-08-31 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 64 | 2023-04-23 |
| Chief Tech/Sci/R&D Officer | 47 | 2024-11-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CHM | Chairman | 48 | 2022-12-01 |
| Director/Board Member | 71 | 2019-11-30 | |
Bill Link
BRD | Director/Board Member | 80 | 2016-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/15/26 | Exercice | Director | 604 | 0.0014% | ||
| 9/15/26 | Exercice | Director | 12,902 | 0.0294% | ||
| 9/15/26 | Exercice | Director | 402 | 0.0009% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.20% | +0.30% | -0.22% | +441.80% | 3.12B | |
| +3.49% | +10.04% | +58.68% | +119.56% | 1,144B | |
| +2.19% | +4.32% | +33.88% | +69.52% | 625B | |
| +2.26% | +5.37% | +24.57% | +97.69% | 511B | |
| +2.58% | +8.37% | +38.71% | +63.14% | 377B | |
| +3.25% | +4.45% | +71.80% | +44.44% | 366B | |
| +1.85% | +6.04% | +21.47% | +49.17% | 291B | |
| +1.76% | +6.07% | +0.43% | +20.98% | 262B | |
| +3.29% | +6.32% | +44.71% | +57.43% | 237B | |
| +2.25% | +5.81% | +27.13% | +101.17% | 194B | |
| Average | +2.06% | +3.80% | +32.12% | +106.49% | 401.1B | |
| Weighted average by Cap. | +1.43% | +4.68% | +40.89% | +80.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 727M 648M 600M 544M 1.02B 68.91B 1.04B 7.2B 2.83B 36.06B 2.73B 2.67B 115B | 920M 819M 759M 688M 1.29B 87.16B 1.31B 9.11B 3.58B 45.61B 3.45B 3.38B 146B |
| Net income | -215M -191M -177M -161M -302M -20.36B -307M -2.13B -836M -10.66B -806M -790M -34B | 9.62M 8.56M 7.93M 7.19M 13.51M 911M 13.74M 95.21M 37.4M 477M 36.08M 35.33M 1.52B |
| Net Debt | -336M -299M -277M -251M -472M -31.85B -480M -3.33B -1.31B -16.67B -1.26B -1.24B -53.18B | -476M -423M -392M -356M -668M -45.06B -679M -4.71B -1.85B -23.58B -1.78B -1.75B -75.22B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | $71.03 | +2.20% | 898,979 |
| 26-10-19 | $69.50 | +2.10% | 682,551 |
| 26-10-16 | $68.07 | -4.11% | 2,871,594 |
| 26-10-15 | $70.99 | -1.80% | 1,398,351 |
| 26-10-14 | $72.29 | +2.08% | 1,166,768 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARS Stock
Select your edition
All financial news and data tailored to specific country editions
